Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors.
Chiappori AA, Eckhardt SG, Bukowski R, Sullivan DM, Ikeda M, Yano Y, Yamada-Sawada T, Kambayashi Y, Tanaka K, Javle MM, Mekhail T, O'bryant CL, Creaven PJ. Chiappori AA, et al. Among authors: creaven pj. Clin Cancer Res. 2007 Apr 1;13(7):2091-9. doi: 10.1158/1078-0432.CCR-06-1586. Clin Cancer Res. 2007. PMID: 17404091 Clinical Trial.
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
Ramnath N, Khushalani N, Toth K, Litwin AM, Intengan ME, Slocum HK, Pendyala L, Smith PF, Stewart CC, Hoffman JL, Javle MM, Berdzik J, Creaven PJ, Rustum YM. Ramnath N, et al. Among authors: creaven pj. Cancer Chemother Pharmacol. 2005 Nov;56(5):447-54. doi: 10.1007/s00280-004-0951-6. Epub 2005 Jun 10. Cancer Chemother Pharmacol. 2005. PMID: 15947933 Clinical Trial.
167 results